Using bacteria as a trojan horse to target oncogenes
Colon cancer cells Source: NCI Center for Cancer Research
We have covered a tremendous array of different modalities here at BSB from chemotherapies, targeted therapies, immunotherapies, encompassing cytotoxics, small molecules, antibodies, bispecifics, various conjugates, and even viral therapy approaches, but what about the potential for bacterial approaches having an impact in cancer research?
This is isn’t something we come across every day week and thus it piqued our interest.
If we want to start thinking about creative ways to hit hard to target oncogenes then maybe we need to think outside the box a bit with some bold ideas…
To learn more about some intriguing translational data and get a heads up on our oncology commentary and insights, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers
